Endocrine Feedback Loop
EFL078 - SGLT1 Inhibition for the Treatment of Post-Bariatric Hypoglycemia
35:00
For our 78th episode, we review a recent Journal of the Endocrine Society (JES) article reporting results from a Phase 2, single-dose trial of an SGLT1 inhibitor for post-bariatric hypoglycemia. This condition can be particularly difficult to diagnose and manage, and current treatments are not uniformly effective or well tolerated, with no FDA-approved therapy currently available. The study…